News
REVBU
0.2897
0.00%
0.00
BUZZ-U.S. STOCKS ON THE MOVE-Gold miners, Dorian LPG, Apple
Dow Jones Industrial Average was up 0.68% at 38,410.08. Wall Street bounced back on Thursday after a selloff in the previous session. Big Tech earnings due later in the day. Top three S&P 500 percentage gainers: Corteva, Etsy and Etsy.
Reuters · 02/01 19:01
BUZZ-U.S. STOCKS ON THE MOVE-CMS Energy, SunPower, Etsy
Wall Street rose on Thursday. Dow Jones Industrial Average was up 0.15% at 38,208.21. Top three S&P 500 percentage gainers: Corteva, Etsy, Norfolk Southern. The Federal Reserve dashed hopes for early interest rate cuts. Big Tech earnings due later in the day. CMS Energy, SunPower, Etsy are among the biggest decliners.
Reuters · 02/01 16:25
BUZZ-U.S. STOCKS ON THE MOVE-Norfolk Southern, Qorvo, Align Technology
U.S. Stock index futures rise on Thursday. Dow e-minis were up 0.12% at 38,326.25. Norfolk Southern, Qorvo, Align Technology are among the top percentage gainers. The focus is on economic data and Big Tech earnings scheduled for later in the day.
Reuters · 02/01 12:32
BUZZ-U.S. STOCKS ON THE MOVE-Sarepta, Hershey, Dollar Tree
U.S. Main stock indexes were sluggish on Monday. Dow Jones Industrial Average was up 0.03% at 38,119.63. Top three S&P 500 percentage gainers: Archer-Daniels-Midland, Hershey, Dollar Tree. Investors await the Federal Reserve's interest rate decision and big-ticket tech earnings this week.
Reuters · 01/29 18:56
BUZZ-U.S. STOCKS ON THE MOVE-Overseas Shipholding, Palisade Bio, Archer-Daniels-Midland
U.S. Main stock indexes had a sluggish start on Monday. The Dow Jones Industrial Average was down 0.04% at 38,093.44. The top three S&P 500 percentage gainers were Align Technology, Palisade Bio, Archer-Daniels-Midland. The Federal Reserve's rate decision and big-ticket tech earnings this week could set the tone.
Reuters · 01/29 15:54
BRIEF-Revelation Biosciences Adjourns 2023 Annual Meeting Of Stockholders To July 7
Reuters · 06/12/2023 21:16
BRIEF-Revelation Biosciences Inc. Announces Financial Results For The Three Months Ended March 31
Reuters · 05/22/2023 13:14
More
Webull provides a variety of real-time REVBU stock news. You can receive the latest news about Revelation Biosciences Inc through multiple platforms. This information may help you make smarter investment decisions.
About REVBU
Revelation Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immunologic therapeutics and diagnostics. Its therapeutic product candidates are based on its therapeutic platform and consist of REVTx-100, which is being developed for the prevention or treatment of infections, including those resulting from surgery, severe burns and antibiotic resistance; REVTx-200, which is being developed as intranasal therapy that focuses to be administered with a commercially available intramuscular (IM) vaccine; REVTx-300, which is being developed as a therapy for the treatment of chronic organ disease, including CKD and NASH; and REVTx-99b, which is being developed for the treatment of food allergies. The Company's diagnostic, REVDx-501 (REVIDTM Rapid Test Kit), is being developed as a rapid point of care or at home diagnostic product that can potentially be used to detect various respiratory viral infections.